Why the study?
Does prophylactic substrate-based catheter ablation reduce the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death?
Population
Patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden…
Design
RCT, Randomized
Authors
Loading...
Supports prophylactic ablation to reduce ICD therapies in post-MI secondary prevention; extends substrate-based evidence to randomized setting.
Does prophylactic substrate-based catheter ablation reduce the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death?
Prophylactic substrate-based catheter ablation reduces the incidence of ICD therapy in patients with prior MI receiving ICDs for secondary prevention.
Reddy et al. (2007) studied this question.